![]() |
So buy. That's where we are. I want to be skeptical, but there are so many others playing that role that it feels too crowded. To me, the better bet is to focus on the one-day sales we get, sales like the one put on Sears (SHLD - commentary - Cramer's Take), or the sale that's going on in Quest Diagnostics (DGX - commentary - Cramer's Take), or how about the sale in WellPoint (WLP - commentary - Cramer's Take)? The fact that we have broken away from our worldwide cohorts makes me feel that the best is yet to come for this year. We have been restrained when they were bad and didn't perform as well when they are good for some time now. Not any more Impressive. At the time of publication, Cramer was long Sears Holdings and Quest Diagnostics.
Jim Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for Action Alerts PLUS. Listen to Cramer's RealMoney Radio show on your computer; just click here. Watch Cramer on "Mad Money" at 6 p.m. ET weeknights on CNBC. Click here to order Cramer's latest book, "Real Money: Sane Investing in an Insane World," click here to get his second book, "You Got Screwed!" and click here to order Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by clicking here. TheStreet.com has a revenue-sharing relationship with Traders' Library under which it receives a portion of the revenue from Traders' Library purchases by customers directed there from TheStreet.com.
Brokerage Partners
|
|||||||||||||||||||||||||||||||||||||||